Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TREKing toward new antidepressants.

Literature DB >> 16936765

TREKing toward new antidepressants.

Joshua A Gordon, Rene Hen.

Abstract

Mesh：

Substances：

Year: 2006 PMID： 16936765 DOI： 10.1038/nn0906-1081

Source DB: PubMed Journal: Nat Neurosci ISSN： 1097-6256 Impact factor: 24.884

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors: M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal: Br J Pharmacol Date: 2014-11-24 Impact factor: 8.739

2. Analyses of gating thermodynamics and effects of deletions in the mechanosensitive channel TREK-1: comparisons with structural models.

Authors: Grigory Maksaev; Adina Milac; Andriy Anishkin; H Robert Guy; Sergei Sukharev
Journal: Channels (Austin) Date: 2011-01-01 Impact factor: 2.581

3. 5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques.

Authors: R Bogdan; H Fitzgibbon; W L Woolverton; C L Bethea; A H Iyo; C A Stockmeier; P B Kyle; M C Austin
Journal: Neurosci Lett Date: 2011-08-17 Impact factor: 3.046

4. The Role of the Two-Pore Domain Potassium Channel TREK-1 in the Therapeutic Effects of Escitalopram in a Rat Model of Poststroke Depression.

Authors: Dai-Hua Lin; Xiang-Rong Zhang; Dong-Qing Ye; Guang-Jun Xi; Jiao-Jie Hui; Shan-Shan Liu; Lin-Jiang Li; Zhi-Jun Zhang
Journal: CNS Neurosci Ther Date: 2015-02-10 Impact factor: 5.243

5. Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling.

Authors: Vibhor Kumar; Jonathan Aow; Naghmeh Rastegar; Michelle Gek Liang Lim; Nicholas O'Toole; Nirmala Arul Rayan; Edita Aliwarga; Danusa Mar Arcego; Hui Ting Grace Yeo; Jen Yi Wong; May Yin Lee; Florian Schmidt; Hajira Shreen Haja; Wai Leong Tam; Tie-Yuan Zhang; Josie Diorio; Christoph Anacker; Rene Hen; Carine Parent; Michael J Meaney; Shyam Prabhakar
Journal: Mol Psychiatry Date: 2022-09-02 Impact factor: 13.437

6. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.

Authors: Jean Mazella; Olivier Pétrault; Guillaume Lucas; Emmanuel Deval; Sophie Béraud-Dufour; Carine Gandin; Malika El-Yacoubi; Catherine Widmann; Alice Guyon; Eric Chevet; Said Taouji; Grégory Conductier; Alain Corinus; Thierry Coppola; Gabriella Gobbi; Jean-Louis Nahon; Catherine Heurteaux; Marc Borsotto
Journal: PLoS Biol Date: 2010-04-13 Impact factor: 8.029

7. Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans.

Authors: Daniel G Dillon; Ryan Bogdan; Jesen Fagerness; Avram J Holmes; Roy H Perlis; Diego A Pizzagalli
Journal: Hum Brain Mapp Date: 2010-02 Impact factor: 5.038